FNWFX
Price
$80.67
Change
-$1.85 (-2.24%)
Updated
Dec 18 closing price
TEQHX
Price
$10.87
Change
-$0.15 (-1.36%)
Updated
Dec 18 closing price
Ad is loading...

FNWFX vs TEQHX

Header iconFNWFX vs TEQHX Comparison
Open Charts FNWFX vs TEQHXBanner chart's image
American Funds New World F3
Price$80.67
Change-$1.85 (-2.24%)
VolumeN/A
CapitalizationN/A
Nuveen Emerging Markets Eq Idx I
Price$10.87
Change-$0.15 (-1.36%)
VolumeN/A
CapitalizationN/A
FNWFX vs TEQHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FNWFX vs. TEQHX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FNWFX is a Buy and TEQHX is a StrongBuy.

FUNDAMENTALS
Fundamentals
FNWFX has more cash in the bank: 64B vs. TEQHX (7.24B). TEQHX pays higher dividends than FNWFX: TEQHX (2.93) vs FNWFX (1.56). FNWFX was incepted earlier than TEQHX: FNWFX (8 years) vs TEQHX (9 years). FNWFX is a more actively managed with annual turnover of: 32.00 vs. TEQHX (7.00). TEQHX has a lower initial minimum investment than FNWFX: TEQHX (100000) vs FNWFX (1000000). TEQHX (12.30) and FNWFX (12.00) have marching annual gain over last year. FNWFX return over 5 years is better than : 16.03 vs. TEQHX (7.78).
FNWFXTEQHXFNWFX / TEQHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years9 years-
Gain YTD10.0279.498106%
Front LoadN/AN/A-
Min. Initial Investment10000001000001,000%
Min. Initial Investment IRAN/AN/A-
Net Assets64B7.24B884%
Annual Yield % from dividends1.562.9353%
Returns for 1 year12.0012.3098%
Returns for 3 years0.71-4.62-15%
Returns for 5 years16.037.78206%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BRC75.93-0.76
-0.99%
Brady Corp
GEN29.38-0.35
-1.18%
Gen Digital
SACH1.24-0.03
-2.36%
Sachem Capital Corp
NN17.55-0.45
-2.50%
NextNav
CANF1.42-0.09
-5.96%
Can-Fite BioPharma Ltd